Olaplex GC gets RSU grant, sells shares for taxes

OLAPLEX HOLDINGS, INC.

Rhea-AI Filing Summary

OLAPLEX HOLDINGS, INC. General Counsel John C. Duffy reported both a stock sale and a new equity award. On March 9, 2026, he sold 34,824 shares of common stock at $1.26 per share in a sell-to-cover transaction to satisfy tax withholding obligations tied to vesting restricted stock units (RSUs).

On March 10, 2026, he received a new grant of 384,615 RSUs under the 2021 Equity Incentive Plan, with each unit representing one future share of common stock. These RSUs vest in four equal installments on March 10, 2027, 2028, 2029, and 2030, contingent on continued employment. After these transactions, he directly holds 1,017,817 shares of common stock.

Insider Trade Summary

Net Seller: 34,824 shares

Net Sell 2 txns

Insider Duffy John C

Role General Counsel

Sold 34,824 shs ($44K)

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	384,615	$0.00	$0.00
Sale	Common Stock	34,824	$1.26	$44K

Holdings After Transaction: Common Stock — 1,017,817 shares (Direct)

Footnotes (2)

1. F1. Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the applicable RSU award agreement.
2. F2. Represents RSUs granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the conditional right to receive one share of Common Stock of the Issuer. The RSUs will vest in four equal installments on each of March 10, 2027, March 10, 2028, March 10, 2029 and March 10, 2030, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Olaplex (OLPX) General Counsel John Duffy report?

John Duffy reported one sale and one equity grant. He sold 34,824 Olaplex shares at $1.26 each to cover tax withholding and received 384,615 restricted stock units that will vest over four years, subject to continued employment conditions.

Was the Olaplex (OLPX) insider stock sale a discretionary sale or tax-related?

The reported sale was tax-related, not a discretionary liquidation. Footnotes state 34,824 shares were sold in a “sell to cover” transaction to satisfy tax withholding obligations arising from vesting restricted stock units under an existing award agreement.

How many RSUs did Olaplex (OLPX) grant to General Counsel John Duffy?

Duffy received 384,615 restricted stock units. Each RSU represents the right to one Olaplex common share. The units vest in four equal tranches on March 10 of 2027, 2028, 2029, and 2030, assuming he remains employed through each vesting date.

What is John Duffy’s Olaplex (OLPX) shareholding after these Form 4 transactions?

Following the reported transactions, Duffy directly holds 1,017,817 shares. This figure reflects his position after selling 34,824 shares for tax withholding purposes and receiving a new grant of 384,615 restricted stock units tied to future vesting.

How will the new Olaplex (OLPX) RSU award vest for John Duffy?

The 384,615 RSUs vest in four equal annual installments. Vesting occurs on March 10, 2027, 2028, 2029, and 2030, provided Duffy remains employed with Olaplex through each vesting date, aligning his compensation with long-term company performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 04:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duffy John C

(Last) (First) (Middle)

C/O OLAPLEX HOLDINGS, INC.

432 PARK AVENUE SOUTH, THIRD FLOOR

(Street)

NEW YORK NY 10016

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
OLAPLEX HOLDINGS, INC. [ OLPX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		S(1)		34,824	D	$1.26	633,202	D
Common Stock	03/10/2026		A		384,615(2)	A	$0	1,017,817	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the applicable RSU award agreement.

2. Represents RSUs granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the conditional right to receive one share of Common Stock of the Issuer. The RSUs will vest in four equal installments on each of March 10, 2027, March 10, 2028, March 10, 2029 and March 10, 2030, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Remarks:

	/s/ John C. Duffy	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.